KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment. Chagraoui J, Girard S, Mallinger L, Mayotte N, et al. Blood 2024 Jan 11:blood.2023021342. doi: 10.1182/blood.2023021342.

Read + Share

Amedeo Smart

Independent Medical Education

Chagraoui J, Girard S, Mallinger L, Mayotte N, et al. KBTBD4-mediated Reduction of MYC Is Critical For Hematopoietic Stem Cell Expansion Upon UM171 Treatment. Blood 2024 Jan 11:blood.2023021342. doi: 10.1182/blood.2023021342.
PMID: 38207291